NGOs Mum On House Cosmetics Bill, But Likely Not Giving Thanks
This article was originally published in The Rose Sheet
Going into the Thanksgiving holiday, neither the Breast Cancer Fund, which heads up the Campaign for Safe Cosmetics, nor the Environmental Working Group had a statement to offer on the Cosmetics Safety Modernization Act, newly introduced in the US House. However, the bill is modeled after 2012 legislation that CSC called a "Trojan Horse" that would enable the existing regulatory system to stay largely in place.
You may also be interested in...
Products marketed for cosmetic use but formulated with drugs are regulated as topical drugs and would be subject to potential OTC user fees, although the products have little similarity with oral or nasal delivery nonprescription drugs also available under FDA's monograph system, consultant David Steinberg says.
The Cosmetic Modernization Amendments of 2015 is touted by small business as a more appropriately sized update to the regulatory framework than the front-running PCPSA. However, some provisions seen as vital are absent from the bill, while its call for FDA to accept CIR safety decisions could be deemed unconstitutional, an FDA official suggests in a letter to Senate HELP Committee Chair Lamar Alexander.
The Environmental Working Group is targeting messaging to independent sales reps at Mary Kay’s annual seminar in an effort to rally support behind the Personal Care Products Safety Act. But Mary Kay’s beef with the proposed bill largely centers on federal preemption, an issue the Personal Care Products Council has suggested will likely drive reform negotiations in the 115th Congress.